Recent Investment Analysts’ Ratings Changes for 1Life Healthcare (ONEM)

Several analysts have recently updated their ratings and price targets for 1Life Healthcare (NASDAQ: ONEM):

  • 5/10/2022 – 1Life Healthcare was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “1Life Healthcare Inc. provides software. The Company offers healthcare application for billing, insurance, planning and other related services. 1Life Healthcare Inc. is based in CA, United States. “
  • 5/6/2022 – 1Life Healthcare had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $16.00 to $11.00.
  • 5/5/2022 – 1Life Healthcare had its price target lowered by analysts at Canaccord Genuity Group Inc. from $18.00 to $14.00. They now have a “buy” rating on the stock.
  • 5/5/2022 – 1Life Healthcare had its price target lowered by analysts at Citigroup Inc. from $17.00 to $14.00.
  • 5/4/2022 – 1Life Healthcare was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $8.50 price target on the stock. According to Zacks, “1Life Healthcare Inc. provides software. The Company offers healthcare application for billing, insurance, planning and other related services. 1Life Healthcare Inc. is based in CA, United States. “
  • 3/29/2022 – 1Life Healthcare is now covered by analysts at Guggenheim. They set a “neutral” rating on the stock.

NASDAQ:ONEM traded up $0.53 during trading hours on Tuesday, hitting $8.52. 2,305,964 shares of the stock traded hands, compared to its average volume of 2,661,278. 1Life Healthcare, Inc. has a fifty-two week low of $5.94 and a fifty-two week high of $38.16. The company has a current ratio of 2.64, a quick ratio of 2.61 and a debt-to-equity ratio of 0.19. The firm has a market cap of $1.65 billion, a price-to-earnings ratio of -4.79 and a beta of 1.87. The firm has a 50 day moving average price of $9.31 and a 200 day moving average price of $13.01.

1Life Healthcare (NASDAQ:ONEMGet Rating) last released its quarterly earnings results on Wednesday, May 4th. The company reported ($0.47) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.49) by $0.02. 1Life Healthcare had a negative net margin of 40.50% and a negative return on equity of 21.62%. The company had revenue of $254.10 million during the quarter, compared to analysts’ expectations of $246.57 million. During the same period in the prior year, the company earned ($0.29) earnings per share. The business’s quarterly revenue was up 109.4% compared to the same quarter last year. Research analysts predict that 1Life Healthcare, Inc. will post -1.85 EPS for the current year.

A number of hedge funds have recently made changes to their positions in ONEM. Morgan Stanley boosted its stake in 1Life Healthcare by 27.5% in the second quarter. Morgan Stanley now owns 1,158,115 shares of the company’s stock valued at $38,287,000 after acquiring an additional 250,082 shares during the last quarter. Swiss National Bank raised its holdings in shares of 1Life Healthcare by 0.7% during the third quarter. Swiss National Bank now owns 182,200 shares of the company’s stock worth $3,690,000 after acquiring an additional 1,200 shares during the period. Principal Financial Group Inc. increased its stake in 1Life Healthcare by 2.8% in the 3rd quarter. Principal Financial Group Inc. now owns 52,110 shares of the company’s stock valued at $1,055,000 after buying an additional 1,405 shares during the last quarter. Teacher Retirement System of Texas increased its stake in 1Life Healthcare by 26.4% in the 3rd quarter. Teacher Retirement System of Texas now owns 13,231 shares of the company’s stock valued at $268,000 after buying an additional 2,764 shares during the last quarter. Finally, Skandinaviska Enskilda Banken AB publ increased its stake in 1Life Healthcare by 5.5% in the 3rd quarter. Skandinaviska Enskilda Banken AB publ now owns 39,277 shares of the company’s stock valued at $795,000 after buying an additional 2,046 shares during the last quarter. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

1Life Healthcare, Inc operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs.

See Also

Receive News & Ratings for 1Life Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 1Life Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.